Proteomics-driven discovery of LCAT as a novel biomarker for liver metastasis in colorectal cancer. Wang Y, Yang Z, Li Z, Huang L, et al. BMC Cancer 2025;25:480.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Yang Z, Li Z, Huang L, et al. Proteomics-driven discovery of LCAT as a novel biomarker for liver metastasis in colorectal cancer. BMC Cancer 2025;25:480.
PMID: 40089671